According to our (Global Info Research) latest study, the global Continuous Glucose Monitoring Sensors market size was valued at US$ 8849 million in 2025 and is forecast to a readjusted size of US$ 27194 million by 2032 with a CAGR of 18.5% during review period.
A continuous glucose monitoring sensor is a core sensing element inserted subcutaneously in a minimally invasive manner, utilizing electrochemical principles to continuously measure glucose concentration in interstitial fluid. Its technical essence lies in converting the weak current signal generated by the glucose oxidase-catalyzed reaction into real-time glucose concentration data that can be interpreted by algorithms. This sensor is a core consumable component of a continuous glucose monitoring system, typically consisting of a flexible substrate, interdigitated electrode layer, and responsive gel layer, achieving up to 14 days of stable in-vivo operation through biocompatible encapsulation. From a technological generational perspective, first-generation sensors rely on oxygen as an electron mediator and are susceptible to "oxygen deficiency" issues. Second-generation sensors employ synthetic redox polymers as mediators, significantly reducing operating voltage and markedly improving anti-interference performance. Currently, sensor technology is evolving from "enzymatic reaction" toward "affinity sensing." The ConA/DexMA dual-network hydrogel sensor developed by East China University of Science and Technology utilizes the competitive reversible binding of dextran and glucose to generate a capacitance signal output, offering potential to overcome the lifespan limitations of traditional enzymatic sensors. Lifecare in Norway is developing an implantable sensor based on osmotic pressure sensing principles, with its latest validation demonstrating the ability to track glucose fluctuations without calibration.
Market Development Opportunities and Key Drivers
Second-generation electrochemical sensor technology has achieved a domestic breakthrough. Sibionics utilized metal redox polymers as electron mediators to solve the "oxygen deficiency" issue, achieving a sensor lifespan of 14 days with a MARD value below 9%, becoming the first calibration-free CGM product in China. Meanwhile, Senseonics' Eversense 365 extended the replacement cycle to 365 days. Lifecare in Norway completed system-level validation for its osmotically-sensed implantable sensor that can operate without calibration. The ConA/DexMA hydrogel sensor developed by East China University of Science and Technology opened new pathways for affinity sensors. The Guangdong Medical Products Administration provided "early intervention and tailored guidance" services to Sibionics, while Yichun City included CGM in its centralized procurement scope.
Market Challenges and Risks
The long-term stability of sensors remains the greatest challenge, as enzyme activity degradation leads to signal drift. Implantable sensors also face biofouling issues such as protein adsorption and cell adhesion. Additionally, signal delay and motion interference continue to impact user experience. Global regulatory requirements are tightening, reflected in the EU MDR, US iCGM standards, and China's NMPA regulations. Furthermore, microfabrication, gel polymerization, and packaging stability remain bottlenecks for mass production.
Downstream Demand Trends
CGM sensors have expanded rapidly from type 1 diabetes to type 2 diabetes. According to the International Diabetes Federation, there are 589 million adults with diabetes globally, with a prevalence rate of approximately 12.8% in China and a prediabetes rate of 35.2%. Sensors provide more precise tools for gestational diabetes management, reducing the risk of maternal and infant complications. Lingxi Bio plans to launch a domestically produced CGM system in 2026, forming a comprehensive solution together with glucose smart rings and blood pressure watches. CGM is extending from home to hospital settings, reducing the burden of frequent fingerstick blood sampling. A 2026 review in the journal Talanta noted that multi-analyte sensing is the direction for next-generation sensors.
Regional Trends
North America leads in sensor source innovation, with Dexcom and Abbott dominating the global market. Senseonics' Eversense 365 received CE certification and is planned for launch in Europe. In the Asia-Pacific region, China has become the most dynamic growth market. Sibionics has served over 2.4 million users, covering nearly 4,000 medical institutions nationwide, with products exported to nearly 100 countries and cumulative output value exceeding 2 billion RMB. East China University of Science and Technology and Shenzhen University continue to produce sensor technology innovations. Sibionics achieved overseas revenue of nearly $40 million in 2025, while MicroTech Medical obtained approval for its CGM in India, and Sinocare experienced explosive growth in Indonesia. The prevalence of diabetes in the Middle East and North Africa exceeds 20%, and demand for CGM is expected to grow significantly.
This report is a detailed and comprehensive analysis for global Continuous Glucose Monitoring Sensors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Continuous Glucose Monitoring Sensors market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Continuous Glucose Monitoring Sensors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Continuous Glucose Monitoring Sensors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Continuous Glucose Monitoring Sensors market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Continuous Glucose Monitoring Sensors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Continuous Glucose Monitoring Sensors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dexcom, Abbott, Senseonics, Minimed, Ascensia, Fibersense, Roche, Medtrum, Sinocare, SIBIONICS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Continuous Glucose Monitoring Sensors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Enzyme-Based Sensor
Non-Enzymatic Sensor
Market segment by Detection Principle
Electrochemical Sensor
Optical Sensor
Affinity-Based Sensors
Market segment by Sampling Mode
Non-Invasive Sensors
Subcutaneous Sensors
Market segment by Monitoring Period
Short-Term Sensors
Long-Term Sensors
Market segment by Application
Diabetes Management
Critical Care Monitoring
Metabolic Health Management
Major players covered
Dexcom
Abbott
Senseonics
Minimed
Ascensia
Fibersense
Roche
Medtrum
Sinocare
SIBIONICS
MicroTech Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Continuous Glucose Monitoring Sensors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Continuous Glucose Monitoring Sensors, with price, sales quantity, revenue, and global market share of Continuous Glucose Monitoring Sensors from 2021 to 2026.
Chapter 3, the Continuous Glucose Monitoring Sensors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Continuous Glucose Monitoring Sensors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Continuous Glucose Monitoring Sensors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Continuous Glucose Monitoring Sensors.
Chapter 14 and 15, to describe Continuous Glucose Monitoring Sensors sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Continuous Glucose Monitoring Sensors. Industry analysis & Market Report on Continuous Glucose Monitoring Sensors is a syndicated market report, published as Global Continuous Glucose Monitoring Sensors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Continuous Glucose Monitoring Sensors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.